Isorhamnetin Attenuates Atherosclerosis by Inhibiting Macrophage Apoptosis via PI3K/AKT Activation and HO-1 Induction

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress

(2013) Lei Gu et al.   PLoS One

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro

(2013) Jing Sun et al.   PLoS One

Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE−/− mice

(2013) Gui-bo Sun et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation

(2012) Maria Salagianni et al.   CIRCULATION

Apamin inhibits THP-1-derived macrophage apoptosis via mitochondria-related apoptotic pathway

(2012) Soo-Jung Kim et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Effect of the Miaoyao Fanggan sachet-derived isorhamnetin on TLR2/4 and NKp46 expression in mice

(2012) Hui Wang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Modulation of Experimental Herpes Encephalitis-Associated Neurotoxicity through Sulforaphane Treatment

(2012) Scott J. Schachtele et al.   PLoS One

Isorhamnetin Suppresses Skin Cancer through Direct Inhibition of MEK1 and PI3-K

(2011) J.-E. Kim et al.   Cancer Prevention Research

Simvastatin Suppresses Apoptosis in Vulnerable Atherosclerotic Plaques Through Regulating the Expression of p53, Bcl-2 and Bcl-xL

(2011) Weiwei Qin et al.   CARDIOVASCULAR DRUGS AND THERAPY

Schisandra chinensis α-iso-cubebenol induces heme oxygenase-1 expression through PI3K/Akt and Nrf2 signaling and has anti-inflammatory activity in Porphyromonas gingivalis lipopolysaccharide-stimulated macrophages

(2011) Sun Young Park et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Protective effects of cynaroside against H2O2-induced apoptosis in H9c2 cardiomyoblasts

(2011) Xiao Sun et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation

(2011) Bing Sun et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation

(2010) Patricia G. Yancey et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Transient Expression of Interferon-Induciblep204in the Early Stage Is Required for Adipogenesis in 3T3-L1 Cells

(2010) Jing Xiao et al.   ENDOCRINOLOGY

Reactive oxygen species, cellular redox systems, and apoptosis

(2010) Magdalena L. Circu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155☆

(2010) Christine Boesch-Saadatmandi et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Macrophage Plasticity in Experimental Atherosclerosis

(2010) Jamila Khallou-Laschet et al.   PLoS One

Cell Death Pathways in Parkinson's Disease: Role of Mitochondria

(2009) Zhi Yao et al.   ANTIOXIDANTS & REDOX SIGNALING

Macrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion Stage

(2009) Emmanuel L. Gautier et al.   CIRCULATION

Antioxidant Properties of Isolated Isorhamnetin from the Sea Buckthorn Marc

(2009) Liu Pengfei et al.   PLANT FOODS FOR HUMAN NUTRITION

Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe −/− Mice

(2008) Edward Thorp et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages

(2008) Yanxia Ning et al.   ATHEROSCLEROSIS

Nuclear Factor E2-Related Factor 2-Dependent Myocardiac Cytoprotection Against Oxidative and Electrophilic Stress

(2008) Hong Zhu et al.   Cardiovascular Toxicology

Mechanisms and consequences of macrophage apoptosis in atherosclerosis

(2008) Tracie Seimon et al.   JOURNAL OF LIPID RESEARCH

CD36/Fatty Acid Translocase, An Inflammatory Mediator, Is Involved in Hyperlipidemia-Induced Exacerbation in Ischemic Brain Injury

(2008) E. Kim et al.   JOURNAL OF NEUROSCIENCE

Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice

(2008) T PARK et al.   PHARMACOLOGICAL RESEARCH

Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner

(2008) Y HWANG et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY